Craneware (CRW.L) Stock Price
Craneware Price
Over the last 19 years Craneware grew revenue by 14.8% annually, reaching 206.47 M USD. Earnings per share have grown at 13.9% per year over the last 19 years. For Craneware, the net margin of 9.6% is up versus 5.7% a few years ago. At today's price the dividend yield works out to roughly 2.85%. The payout ratio is around 112% of earnings. The dividend has grown at 14.3% per year over the past 18 years.
Craneware stock price
Craneware business model & stock analysis
Frequently asked questions about Craneware
Craneware PLC is a software company that specializes in healthcare revenue management solutions. Their business model revolves around providing hospitals and healthcare organizations with innovative software solutions to optimize financial performance. Craneware's software helps healthcare providers ensure accurate pricing, improve revenue integrity, and enhance compliance with regulations. By leveraging their robust technology platform, the company aims to assist healthcare organizations in maximizing revenue, reducing costs, and effectively managing financial processes. With a strong focus on healthcare revenue management, Craneware PLC continues to drive efficiency and profitability in the healthcare industry.
Craneware PLC primarily operates in the healthcare industry.
The main competitors of Craneware PLC in the market include healthcare technology companies such as Cerner Corporation, Allscripts Healthcare Solutions, and Epic Systems Corporation.
Craneware PLC is a leading healthcare software company based in Edinburgh, Scotland. Founded in 1999, Craneware specializes in developing innovative solutions to help hospitals and healthcare organizations optimize financial performance and improve patient outcomes. Over the years, the company has established a strong reputation for its market-leading revenue integrity and cost management solutions. With a customer base spanning the United States, the United Kingdom, and other international markets, Craneware continues to grow and expand its presence in the healthcare industry. The company's commitment to delivering exceptional results and its focus on driving value for its customers have made Craneware an industry leader in healthcare software solutions.
Craneware PLC, a leading software company, has achieved numerous significant milestones throughout its history. The company has successfully expanded its global presence, establishing a strong client base across the United States and other international markets. Craneware PLC has consistently delivered innovative software solutions tailored to the specific needs of the healthcare industry, enabling healthcare organizations to optimize their financial performance. The company has also received prestigious accolades, including recognition as one of the UK's fastest-growing technology companies. Craneware PLC's commitment to continuous growth and driving positive change in the healthcare sector has positioned it as a trusted and reliable partner for organizations seeking financial excellence and operational efficiency.
Craneware PLC primarily operates in the United States and the United Kingdom.
Craneware PLC represents a strong commitment to ethical business practices and transparency. The company's corporate philosophy revolves around delivering value to its customers by providing innovative revenue integrity solutions for the healthcare industry. Craneware PLC values integrity, accountability, and customer success, ensuring that its products and services meet the evolving needs of healthcare providers. With a focus on driving financial performance and optimizing revenue, Craneware PLC offers sophisticated software solutions that empower healthcare organizations to enhance their operational efficiency and improve financial outcomes. By prioritizing customer satisfaction and promoting a culture of excellence, Craneware PLC continues to be a trusted and respected name in the healthcare software industry.
13 analysts currently rate the Craneware stock: 12 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Craneware share trades at 12.00 EUR (13.51 USD).
The Craneware share (CRW.L) is listed on 4 stock exchanges, including: London (CRW.L), Frankfurt (3X6.F).
Craneware PLC is an internationally operating company specializing in providing software solutions in the field of hospital administration. The company has been listed on the London Stock Exchange since 2007 and is headquartered in Edinburgh, Scotland. Craneware's business model is focused on helping hospitals optimize their processes and increase their revenues. Craneware offers a range of software products that contribute to maximizing cost efficiency and revenue by enabling better management of services, billing, and contracts. One of Craneware's key divisions is the provision of billing management software. This software assists hospitals in creating more accurate and faster billing, leading to increased efficiency and faster payment. The software can also help reduce billing errors and avoid fines. Another important area of Craneware is contract management. The company offers a software platform that allows hospitals to better manage their contracts with suppliers and insurance companies. This includes monitoring contract terms and providing reports on the performance of contract partners. Craneware also offers tools to support cost calculations. This software allows hospitals to more accurately forecast their costs and better plan their procurement and management budgets. In addition, Craneware offers training and consulting services to support hospitals and their staff in implementing the software and improving their processes. In addition to its extensive product range, Craneware is also committed to continuously improving and updating its software. The company invests significantly in research and development to ensure that its products meet the changing needs of customers and the industry. In 2019, Craneware generated revenue of £76.8 million. Most of the revenue was generated in the UK and the US, where the company has offices. Craneware has customers in more than 50 countries worldwide and is committed to expanding its presence in key growth markets. In summary, Craneware's business model is focused on providing innovative software solutions for hospital administration to improve cost efficiency and facility performance. The company's various divisions offer a wide range of products and services aimed at optimizing revenue factors and strategic options for hospitals and their staff.
The revenue of Craneware is 206.47 M USD. This figure is based on current financial data and reflects the company's business performance.
The profit of Craneware is 19.78 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Craneware is currently 23.74. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Craneware stock.
The price-to-sales ratio (P/S) of Craneware is currently 2.27. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Craneware stock.
The Eulerpool Quality Score for Craneware is 8/10.
The ISIN of Craneware is GB00B2425G68. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Craneware is A0MS3H. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Craneware is CRW.L. The ticker symbol is used to trade Craneware shares on the stock exchange.
Craneware stock
Craneware Peer Group
Craneware Ticker
Craneware FIGI
All fundamentals and in-depth analysis of Craneware
Our stock analysis for Craneware stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Craneware. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.